Non-Discrimination Notice

Tokai ARMOR3

Tokai ARMOR3– A study of investigational drug for prostate cancer

Some Requirements:

1. Male age 18 or over
2. Carrier of the AR-V7 splice variant
3. Meet PSA criteria

Sponsored by: Tokai
Length of Study: 2 years
Enrollment: Open

Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.

Research Department (315) 478-4185, option 7

Our Investigator for this study is Christopher Pieczonka, M.D.